Dyadic Advancing Towards Human Clinical Trial of its SARS-CoV-2-S-RBD vaccine candidate, DYAI-100

Matthew Durham
Omnidynamic Marketing

Brenda Snow
Authentic Patient Voice

Paul Theisen
Patient Acquisition

Liz Kane
Impactful Strategy

David Linetsky
Point-of-Care Marketing

Pat Purcell
Meeting Engagement

Suma Ramadas, PhD
Medical Affairs

Matt Turner
Patient Affordability

Bud Bilanich
Success Coach

Joey Cohen
Medication Adherence

Stacey Gandler
Brand Nourishment

Frank Burrell
Scientific Storytelling

Daniel Sontupe
Market Access

Amy Giles
Increasing Engagement